正海生物：接受华西证券调研

Group 1 - Zhenghai Biological announced that on January 20, 2026, it will be receiving a research visit from Huaxi Securities, with the company's board secretary, vice general manager, and chief financial officer, Ms. Zhao Li, participating in the reception and answering investor questions [1]